Accumulation of porphyrins in plasma and tissues of dogs after δ-aminolevulinic acid administration: Implications for photodynamic therapy

Norman G. Egger, Massoud Motamedi, Mariela Pow-Sang, Eduardo Orihuela, Karl Anderson

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Protoporphyrin accumulates in tissues after administration of δ-aminolevulinic acid, and can be used as a photosensitizer for photodynamic therapy. To determine the distribution of porphyrins in a large animal model after administration of this porphyrin precursor, δ-aminolevulinic acid was administered to anesthetized dogs (100 mg/kg body weight intravenously) and porphyrin concentrations were measured in tissues (liver, pancreas, prostate, bladder, muscle and skin), plasma and urine for 6-10 h. Porphyrins increased markedly (up to 50-fold) in plasma within 1 h, were still markedly increased at 8 h, and consisted mostly of coproporphyrin III and protoporphyrin. Tissue porphyrin concentrations increased more slowly, were highest in liver, pancreas and prostate 7-10 h after δ-aminolevulinic acid administration, and were predominantly protoporphyrin. Maximum porphyrin concentrations in liver were 3- and 4-fold higher than in pancreas and prostate, respectively. Urinary δ-aminolevulinic acid excretion increased and was greatest 2-4 h after dosing; urinary porphobilinogen and porphyrins increased more gradually and remained increased up to at least 8 h. Coproporphyrin III was the predominant porphyrin in urine at all times, but hepta-, hexa- and pentacarboxyl porphyrins increased proportionally after administration of δ-aminolevulinic acid. These results indicate that porphyrins accumulate in plasma as well as tissues and urine after administration of δ-aminolevulinic acid, and may contribute to tumor necrosis during photodynamic therapy.

Original languageEnglish (US)
Pages (from-to)362-370
Number of pages9
JournalPharmacology
Volume52
Issue number6
StatePublished - Jun 1996

Fingerprint

Aminolevulinic Acid
Porphyrins
Photochemotherapy
Dogs
Prostate
Pancreas
Urine
Liver
Porphobilinogen
Photosensitizing Agents
Urinary Bladder
Necrosis
Animal Models
Body Weight
Muscles

Keywords

  • δ-aminolevulinic acid
  • Cancer
  • Photodynamic therapy
  • Porphyrins
  • Protoporphyrin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Accumulation of porphyrins in plasma and tissues of dogs after δ-aminolevulinic acid administration : Implications for photodynamic therapy. / Egger, Norman G.; Motamedi, Massoud; Pow-Sang, Mariela; Orihuela, Eduardo; Anderson, Karl.

In: Pharmacology, Vol. 52, No. 6, 06.1996, p. 362-370.

Research output: Contribution to journalArticle

@article{deba1950a4194bb58a249af9875c9f92,
title = "Accumulation of porphyrins in plasma and tissues of dogs after δ-aminolevulinic acid administration: Implications for photodynamic therapy",
abstract = "Protoporphyrin accumulates in tissues after administration of δ-aminolevulinic acid, and can be used as a photosensitizer for photodynamic therapy. To determine the distribution of porphyrins in a large animal model after administration of this porphyrin precursor, δ-aminolevulinic acid was administered to anesthetized dogs (100 mg/kg body weight intravenously) and porphyrin concentrations were measured in tissues (liver, pancreas, prostate, bladder, muscle and skin), plasma and urine for 6-10 h. Porphyrins increased markedly (up to 50-fold) in plasma within 1 h, were still markedly increased at 8 h, and consisted mostly of coproporphyrin III and protoporphyrin. Tissue porphyrin concentrations increased more slowly, were highest in liver, pancreas and prostate 7-10 h after δ-aminolevulinic acid administration, and were predominantly protoporphyrin. Maximum porphyrin concentrations in liver were 3- and 4-fold higher than in pancreas and prostate, respectively. Urinary δ-aminolevulinic acid excretion increased and was greatest 2-4 h after dosing; urinary porphobilinogen and porphyrins increased more gradually and remained increased up to at least 8 h. Coproporphyrin III was the predominant porphyrin in urine at all times, but hepta-, hexa- and pentacarboxyl porphyrins increased proportionally after administration of δ-aminolevulinic acid. These results indicate that porphyrins accumulate in plasma as well as tissues and urine after administration of δ-aminolevulinic acid, and may contribute to tumor necrosis during photodynamic therapy.",
keywords = "δ-aminolevulinic acid, Cancer, Photodynamic therapy, Porphyrins, Protoporphyrin",
author = "Egger, {Norman G.} and Massoud Motamedi and Mariela Pow-Sang and Eduardo Orihuela and Karl Anderson",
year = "1996",
month = "6",
language = "English (US)",
volume = "52",
pages = "362--370",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Accumulation of porphyrins in plasma and tissues of dogs after δ-aminolevulinic acid administration

T2 - Implications for photodynamic therapy

AU - Egger, Norman G.

AU - Motamedi, Massoud

AU - Pow-Sang, Mariela

AU - Orihuela, Eduardo

AU - Anderson, Karl

PY - 1996/6

Y1 - 1996/6

N2 - Protoporphyrin accumulates in tissues after administration of δ-aminolevulinic acid, and can be used as a photosensitizer for photodynamic therapy. To determine the distribution of porphyrins in a large animal model after administration of this porphyrin precursor, δ-aminolevulinic acid was administered to anesthetized dogs (100 mg/kg body weight intravenously) and porphyrin concentrations were measured in tissues (liver, pancreas, prostate, bladder, muscle and skin), plasma and urine for 6-10 h. Porphyrins increased markedly (up to 50-fold) in plasma within 1 h, were still markedly increased at 8 h, and consisted mostly of coproporphyrin III and protoporphyrin. Tissue porphyrin concentrations increased more slowly, were highest in liver, pancreas and prostate 7-10 h after δ-aminolevulinic acid administration, and were predominantly protoporphyrin. Maximum porphyrin concentrations in liver were 3- and 4-fold higher than in pancreas and prostate, respectively. Urinary δ-aminolevulinic acid excretion increased and was greatest 2-4 h after dosing; urinary porphobilinogen and porphyrins increased more gradually and remained increased up to at least 8 h. Coproporphyrin III was the predominant porphyrin in urine at all times, but hepta-, hexa- and pentacarboxyl porphyrins increased proportionally after administration of δ-aminolevulinic acid. These results indicate that porphyrins accumulate in plasma as well as tissues and urine after administration of δ-aminolevulinic acid, and may contribute to tumor necrosis during photodynamic therapy.

AB - Protoporphyrin accumulates in tissues after administration of δ-aminolevulinic acid, and can be used as a photosensitizer for photodynamic therapy. To determine the distribution of porphyrins in a large animal model after administration of this porphyrin precursor, δ-aminolevulinic acid was administered to anesthetized dogs (100 mg/kg body weight intravenously) and porphyrin concentrations were measured in tissues (liver, pancreas, prostate, bladder, muscle and skin), plasma and urine for 6-10 h. Porphyrins increased markedly (up to 50-fold) in plasma within 1 h, were still markedly increased at 8 h, and consisted mostly of coproporphyrin III and protoporphyrin. Tissue porphyrin concentrations increased more slowly, were highest in liver, pancreas and prostate 7-10 h after δ-aminolevulinic acid administration, and were predominantly protoporphyrin. Maximum porphyrin concentrations in liver were 3- and 4-fold higher than in pancreas and prostate, respectively. Urinary δ-aminolevulinic acid excretion increased and was greatest 2-4 h after dosing; urinary porphobilinogen and porphyrins increased more gradually and remained increased up to at least 8 h. Coproporphyrin III was the predominant porphyrin in urine at all times, but hepta-, hexa- and pentacarboxyl porphyrins increased proportionally after administration of δ-aminolevulinic acid. These results indicate that porphyrins accumulate in plasma as well as tissues and urine after administration of δ-aminolevulinic acid, and may contribute to tumor necrosis during photodynamic therapy.

KW - δ-aminolevulinic acid

KW - Cancer

KW - Photodynamic therapy

KW - Porphyrins

KW - Protoporphyrin

UR - http://www.scopus.com/inward/record.url?scp=0029824659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029824659&partnerID=8YFLogxK

M3 - Article

C2 - 8844786

AN - SCOPUS:0029824659

VL - 52

SP - 362

EP - 370

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 6

ER -